Concorde Asset Management, LLC - ANIXA BIOSCIENCES INC ownership

ANIXA BIOSCIENCES INC's ticker is ANIX and the CUSIP is 03528H109. A total of 34 filers reported holding ANIXA BIOSCIENCES INC in Q2 2021. The put-call ratio across all filers is 0.68 and the average weighting 0.0%.

Quarter-by-quarter ownership
Concorde Asset Management, LLC ownership history of ANIXA BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$50,551
+2.0%
15,459
-0.1%
0.05%0.0%
Q2 2023$49,539
-24.8%
15,481
-0.1%
0.05%
-22.0%
Q4 2022$65,875
-16.6%
15,500
-3.0%
0.06%
-33.0%
Q3 2022$79,000
+61.2%
15,975
-0.2%
0.09%
+18.9%
Q2 2022$49,000
+11.4%
16,0000.0%0.07%
+155.2%
Q1 2022$44,000
-8.3%
16,0000.0%0.03%0.0%
Q4 2021$48,000
-22.6%
16,000
+23.1%
0.03%
-19.4%
Q3 2021$62,000
+24.0%
13,0000.0%0.04%
+28.6%
Q2 2021$50,000
-18.0%
13,0000.0%0.03%
-20.0%
Q1 2021$61,00013,0000.04%
Other shareholders
ANIXA BIOSCIENCES INC shareholders Q2 2021
NameSharesValueWeighting ↓
Concorde Asset Management, LLC 13,000$50,0000.03%
B. Riley Wealth Management, Inc. 12,000$47,0000.01%
Accel Wealth Management 1,250$5,0000.00%
Tower Research Capital LLC (TRC) 19,979$77,0000.00%
Spire Wealth Management 17,500$68,0000.00%
UBS Group AG 687,302$2,667,0000.00%
SEGALL BRYANT & HAMILL, LLC 17,400$68,0000.00%
Renaissance Technologies 124,499$483,0000.00%
TWO SIGMA ADVISERS, LP 61,638$239,0000.00%
BANK OF AMERICA CORP /DE/ 21$00.00%
View complete list of ANIXA BIOSCIENCES INC shareholders